Perigo, Cresencia .

HRN: 23-61-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2026
CEFTRIAXONE 1G (VIAL)
02/25/2026
03/04/2026
IV
2 Grams
Q24
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: